Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
SSL International plc is a manufacturer and distributor of healthcare products sold into consumer markets worldwide. SSL has a diverse portfolio of consumer products which include Durex and Scholl More
Mundipharma International seeks products in analgesia, anesthesia and oncology to market through a pan-European sales force. More
Zambon Group is a privately-held multinational pharmaceutical company that in-licenses pharmaceutical products from the discovery to late stage development or already on the market. More
PALAU PHARMA is a newly created biopharmaceutical company devoted to the discovery and development of small molecules for the treatment of inflammatory and autoimmune conditions. More
Alliance pharmaceuticals is a dynamic UK pharmaceutical company with a successful acquisition and partnership track record More
Lipocine develop branded products using its proprietary drug delivery technologies. They provide discovery and delivery support for challenging drugs. They issued 14 patents and corporate partnerships More
Pharmaceutical sales to the UK hospital market. More
Navamedic is a Scandinavian specialty pharma company focusing on registration and marketing. Therapeutic areas include OA, Medical Nutrition, Oral Medicine, Female Care, Addictions and Dermatology. More
Supernus Pharmaceuticals is a specialty pharmaceutical company specific expertise in developing differentiated products in collaboration with partners and for its own CNS product portfolio. More
Medical School - Teaching Hospital - Research Institution More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Attention-deficit/hyperactivity disorder
- Autism
- Brain injury
- Cerebral palsy
- Cerebrovascular disorders
- Dyslexia
- Emesis
- Encephalitis
- Epilepsy
- Huntington's disease
- Hypersomnia
- Insomnia
- Meningitis, aseptic
- Meningitis, bacterial
- Meningitis, viral
- Migraine
- Myalgic encephalomyelitis
- Narcolepsy
- Neoplastic meningitis
- Nerve regeneration
- Neuropathy, AIDS-related
- Neuropathy, diabetic
- Neuropathy, peripheral
- Neuroprotection
- Premenstrual dysphoric disorder
- Sleep apnea
- Sleep disorders
- Spasticity
- Spinal cord injury
- Stroke
- Tourette's syndrome
- Vertigo
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us